Skip to content
Home/Companies/Healthcare/Kojin Therapeutics
KT

Kojin Therapeutics

Healthcare·US·Exited 2025·Held 4yr

Kojin Therapeutics is a healthcare company, headquartered in United States.

Entry
2021
Hold
4yr
Exit
2025
Est. EV
–

Who owns Kojin Therapeutics?

Kojin Therapeutics was owned by Cathay Capital through Cathay Health (2021 vintage) from 2021 to 2025, exited via Write-off.

Hand-verified · updated 2026-04-21

Cathay Capital
Investor
Cathay Capital
Cathay Health · 2021 · Growth

Key facts

HQUnited States
SectorHealthcare
Exit Type
Write-off
Buyer
–
MOIC
–
Exit Year
2025

More from Cathay Health

Other portfolio companies in the same fund.

Ascend Gene & Cell Therapies
Active
HealthcareFrance
Ganymed Robotics
Active
HealthcareFrance· 2022
Moon Surgical
Active
HealthcareFrance· 2022
Initiate Studios
Active
HealthcareUS· 2021
Tissium
Active
HealthcareFrance· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings